Market Research Logo

Nucleus Replacement - Medical Devices Pipeline Assessment, 2017

Nucleus Replacement - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, “Nucleus Replacement - Medical Devices Pipeline Assessment, 2017 provides an overview of Nucleus Replacement currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Nucleus Replacement pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Nucleus Replacement under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Nucleus Replacement and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Nucleus Replacement under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Nucleus Replacement Overview
3 Products under Development
3.1 Nucleus Replacement - Pipeline Products by Stage of Development
3.2 Nucleus Replacement - Pipeline Products by Territory
3.3 Nucleus Replacement - Pipeline Products by Regulatory Path
3.4 Nucleus Replacement - Pipeline Products by Estimated Approval Date
3.5 Nucleus Replacement - Ongoing Clinical Trials
4 Nucleus Replacement - Pipeline Products under Development by Companies
4.1 Nucleus Replacement Companies - Pipeline Products by Stage of Development
4.2 Nucleus Replacement - Pipeline Products by Stage of Development
5 Nucleus Replacement Companies and Product Overview
5.1 Arthro Kinetics AG Company Overview
5.1.1 Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview
5.2 Chi2Gel Ltd. Company Overview
5.2.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Clariance Inc Company Overview
5.3.1 Clariance Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 CryoLife Inc Company Overview
5.4.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 DePuy Synthes Inc Company Overview
5.5.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Gentis Inc Company Overview
5.6.1 Gentis Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Hydrospine, Inc. Company Overview
5.7.1 Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 Ortho Regenerative Technologies Inc Company Overview
5.8.1 Ortho Regenerative Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Raymedica, LLC Company Overview
5.9.1 Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 Replication Medical Inc Company Overview
5.10.1 Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Spine Wave Inc Company Overview
5.11.1 Spine Wave Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Stryker Corporation Company Overview
5.12.1 Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.13 TranS1 Inc Company Overview
5.13.1 TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Vertebral Technologies Inc Company Overview
5.14.1 Vertebral Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Zimmer Biomet Holdings Inc Company Overview
5.15.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Nucleus Replacement- Recent Developments
6.1 Apr 27, 2017: SpinalCyte Receives New Australian Patent
6.2 Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results
6.3 Apr 27, 2017: RTI Surgical Announces 2017 First Quarter Results
6.4 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results
6.5 Apr 25, 2017: Stryker reports first quarter 2017 results
6.6 Apr 12, 2017: Brian May Joins Spine Wave as Executive Vice President, Research and Development
6.7 Apr 06, 2017: SpinalCyte Receives New European Patent
6.8 Feb 23, 2017: RTI Surgical Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth
6.9 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results
6.10 Feb 09, 2017: SpinalCyte Announces New U.S. Patent
6.11 Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results
6.12 Jan 26, 2017: RTI Surgical Names Camille Farhat Chief Executive Officer
6.13 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook
6.14 Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition
6.15 Jan 17, 2017: RTI Surgical Extends Deadline for Nominating Directors to the Board
6.16 Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters
6.17 Jan 10, 2017: Stryker provides 2016 preliminary net sales results
6.18 Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results
6.19 Dec 14, 2016: RTI Surgical Names Robert P. Jordheim Interim CEO
6.20 Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection
6.21 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results
6.22 Oct 27, 2016: Stryker reports third quarter 2016 results
6.23 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results
6.24 Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results
6.25 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors
6.26 Sep 06, 2016: CryoLife Appoints James McDermid as Chief Human Resources Officer
6.27 Aug 15, 2016: RTI Surgical Announces CEO Brian Hutchison to Retire
6.28 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results
6.29 Jul 27, 2016: RTI Surgical Announces 2016 Second Quarter Results
6.30 Jul 25, 2016: CryoLife Reports Second Quarter 2016 Financial Results
6.31 Jul 21, 2016: Stryker reports second quarter 2016 results
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Nucleus Replacement - Pipeline Products by Stage of Development
Table 2: Nucleus Replacement - Pipeline Products by Territory
Table 3: Nucleus Replacement - Pipeline Products by Regulatory Path
Table 4: Nucleus Replacement - Pipeline Products by Estimated Approval Date
Table 5: Nucleus Replacement - Ongoing Clinical Trials
Table 6: Nucleus Replacement Companies - Pipeline Products by Stage of Development
Table 7: Nucleus Replacement - Pipeline Products by Stage of Development
Table 8: Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview
Table 9: NuReS - Product Status
Table 10: NuReS - Product Description
Table 11: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Chi2Disc - Product Status
Table 13: Chi2Disc - Product Description
Table 14: Clariance Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: NucleoFill - Product Status
Table 16: NucleoFill - Product Description
Table 17: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Biodisc Nucleus Pulposus Replacement - Product Status
Table 19: Biodisc Nucleus Pulposus Replacement - Product Description
Table 20: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Hydrafil - Product Status
Table 22: Hydrafil - Product Description
Table 23: Gentis Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: DiscCell - Product Status
Table 25: DiscCell - Product Description
Table 26: Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Intervertebral Disc Repair System - Product Status
Table 28: Intervertebral Disc Repair System - Product Description
Table 29: Ortho Regenerative Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Nucleus Pulposus Repair Device - Product Status
Table 31: Nucleus Pulposus Repair Device - Product Description
Table 32: Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 33: HydraFlex Nucleus Arthroplasty System - Product Status
Table 34: HydraFlex Nucleus Arthroplasty System - Product Description
Table 35: Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: NeuDisc - Product Status
Table 37: NeuDisc - Product Description
Table 38: Spine Wave Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: NuCore Injectable Nucleus - Product Status
Table 40: NuCore Injectable Nucleus - Product Description
Table 41: NuCore RPXL Injectable Nucleus - Product Status
Table 42: NuCore RPXL Injectable Nucleus - Product Description
Table 43: Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Aquarelle - Product Status
Table 45: Aquarelle - Product Description
Table 46: TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Percutaneous Nucleus Replacement - Product Status
Table 48: Percutaneous Nucleus Replacement - Product Description
Table 49: Vertebral Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: InterCushion Disc Nucleus Replacement System - Product Status
Table 51: InterCushion Disc Nucleus Replacement System - Product Description
Table 52: Vertebral Technologies Inc - Ongoing Clinical Trials Overview
Table 53: InterCushion Disc Nucleus Replacement System - A Pilot Clinical Study to Assess the Safety and Effectiveness of the InterCushion Disc Nucleus Prosthesis in Patients Receiving Discectomy
Table 54: Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Newcleus - Product Status
Table 56: Newcleus - Product Description
Table 57: Regain Lumbar Artificial Disc - Product Status
Table 58: Regain Lumbar Artificial Disc - Product Description
Table 59: Glossary
1.2 List of Figures
Figure 1: Nucleus Replacement - Pipeline Products by Stage of Development
Figure 2: Nucleus Replacement - Pipeline Products by Territory
Figure 3: Nucleus Replacement - Pipeline Products by Regulatory Path
Figure 4: Nucleus Replacement - Pipeline Products by Estimated Approval Date
Figure 5: Nucleus Replacement - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report